Custom Life Science Services
Custom Life Science Services
STA PHARMACEUTICAL US LLC WuXi TIDES (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoicacid | 1640968-91-7, 5GR
WuXi TIDES (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoicacid, 1640968-91-7 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoic acid | C([C@@](CCCCCCCCC=C)(C)NC(=O)OCC1C=2C=CC=CC2C=3C=CC=CC31)(=O)O | M.F. C28H35NO4, M.W. 449.59
BIOSEARCH TECHNOLOGIES INC EZ-Tn5 Transposase, 10 units @ 1 U/LA hyperactive form of the Tn5 transposase optimised for in vitro transposon mutagenesis (transposomics).
EZ-Tn5™ Transposase is a hyperactive Tn5 transposase for random insertion of an EZ-Tn5 Transposon into any cloned DNA in vitro or for preparing an EZ-Tn5 Transposome for random insertion of a EZ-Tn5 Transposon into the genomic DNA of living bacteria.
Cell Biolabs Inc QuickTiter™ MuLV Core Antigen ELISA Kit, 96 assays
Cell Biolabs' QuickTiter™ MuLV Core Antigen ELISA Kit measures the p30 core antigen of MuLV with sensitivity as low as 300 pg/mL. The kit provides sufficient reagents for 96 assays including standards and unknown samples.
BD Cell Analysis 3P CS&T IVD Beads, 50 tests
For the BD FACSVia system: The BD CS&T Beads are intended for use on the BD FACSVia flow cytometer system with BD FACSVia clinical software for the verification of optical and fluidic performance and to adjust compensation on the flow cytometer. For the BD FACSLyric flow cytometer: BD CS&T beads, in conjunction with BD FACSuite Clinical software, provide a standardized method for the quality control of optics, electronics, and fluidics, and for adjusting detector voltages and fluorescence compensation on the BD FACSLyric flow cytometer.
STA PHARMACEUTICAL US LLC WuXi TIDES N-Fmoc-3-(trifluoromethoxy)-D-phenylalanine | 1260587-40-3, 5GR
WuXi TIDES N-Fmoc-3-(trifluoromethoxy)-D-phenylalanine, 1260587-40-3 | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-(trifluoromethoxy)phenyl)propanoic acid | O=C(N[C@H](CC1=CC=CC(OC(F)(F)F)=C1)C(=O)O)OCC2C3=CC=CC=C3C4=CC=CC=C42 | M.F. C25H20F3NO5, M.W. 471.43
STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-D-Aad-OH | 218457-73-9, 25GR
WuXi TIDES Fmoc-D-Aad-OH, 218457-73-9 | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hexanedioic acid | O=C(O)CCC[C@H](C(O)=O)NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O | M.F. C21H21NO6, M.W. 383.4
STA PHARMACEUTICAL US LLC WuXi TIDES (S)-2-(Fmoc-amino)-5-phenyl-4-pentenoic acid | 215190-24-2, 100GR
WuXi TIDES (S)-2-(Fmoc-amino)-5-phenyl-4-pentenoic acid, 215190-24-2 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpent-4-enoic acid | O=C(O)[C@@H](NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)CC=CC4=CC=CC=C4 | M.F. C26H23NO4, M.W. 413.47
STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Cys(Boc-aminopropyl)-OH | 173963-91-2, 100GR
WuXi TIDES Fmoc-L-Cys(Boc-aminopropyl)-OH, 173963-91-2 | N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(3-((tert-butoxycarbonyl)amino)propyl)-L-cysteine | CC(C)(OC(NCCCSC[C@H](NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)C(O)=O)=O)C | M.F. C26H32N2O6S, M.W. 500.61
STA PHARMACEUTICAL US LLC WuXi TIDES (2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-phenylpropanoic acid | 881920-86-1, 100GR
WuXi TIDES (2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-phenylpropanoic acid, 881920-86-1 | 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylpropanoic acid | CC(NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)(C(O)=O)C4=CC=CC=C4 | M.F. C24H21NO4, M.W. 387.44
STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-(2S,4S)-4-amino-1-benzoyl-pyrrolidine-2-carboxylic acid | 204321-85-7, 1GR
WuXi TIDES Fmoc-(2S,4S)-4-amino-1-benzoyl-pyrrolidine-2-carboxylic acid, 204321-85-7 | (2S,4S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-1-benzoylpyrrolidine-2-carboxylic acid | O=C(N1C[C@@H](NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)C[C@H]1C(O)=O)C5=CC=CC=C5 | M.F. C27H24N2O5, M.W. 456.5
STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Oic-OH | 130309-37-4, 100GR
WuXi TIDES Fmoc-L-Oic-OH, 130309-37-4 | (2S,3aS,7aS)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)octahydro-1H-indole-2-carboxylic acid | C1CC[C@H]2[C@@H](C1)C[C@@H](C(=O)O)N2C(=O)OCC3C4=CC=CC=C4C5=CC=CC=C53 | M.F. C24H25NO4, M.W. 391.47
STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-D-Thr(HPO3Bzl)-OH | 937171-63-6, 5GR
WuXi TIDES Fmoc-D-Thr(HPO3Bzl)-OH, 937171-63-6 | N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-((benzyloxy)(hydroxy)phosphoryl)-D-threonine | C[C@H](OP(O)(OCC1=CC=CC=C1)=O)[C@@H](NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)C(O)=O | M.F. C26H26NO8P, M.W. 511.47
STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-(S)-3-Amino-3-(3,5-dimethoxy-phenyl)-propionicacid | 501015-38-9, 10GR
WuXi TIDES Fmoc-(S)-3-Amino-3-(3,5-dimethoxy-phenyl)-propionicacid, 501015-38-9 | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dimethoxyphenyl)propanoic acid | COC1=CC(OC)=CC([C@@H](NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)CC(O)=O)=C1 | M.F. C26H25NO6, M.W. 447.49
STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Gln(Trt)-OPfp | 132388-65-9, 1GR
WuXi TIDES Fmoc-L-Gln(Trt)-OPfp, 132388-65-9 | perfluorophenyl N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N5-trityl-L-glutaminate | O=C(OC1=C(F)C(F)=C(F)C(F)=C1F)[C@@H](NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)CCC(NC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)=O | M.F. C45H33F5N2O5, M.W. 776.76